Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sanofi-aventis' Sanofi Pasteur has signed a research and development pact with the University of California, San Diego (UC San Diego), US, for its experimental acne vaccine and treatment.
Subscribe to our email newsletter
The deal includes a two-year research collaboration with Chun-Ming Huang and his associates at UC San Diego School of Medicine for further research and development.
Further, the financial terms of the agreement were not disclosed.
Sanofi Global Research & Development president Elias Zerhouni said this opportunity could provide an immunotherapeutic product with benefits and a novel mechanism of action to address an unmet medical need.
"This investigational vaccine and treatment may lead to a better solution for the many who suffer from this skin disease," Zerhouni said.